Find latest Anemias videos · 100+ videos
XV Eurasian Hematology-Oncology Congress - EHOC 2024
A

Luspatercept and Blood Transfusion Management in Beta Thalassemia and MDS

By XV Eurasian Hematology-Oncology Congress - EHOC 2024 FEATURING Anıl Tombak
By XV Eurasian Hematology-Oncology Congress - EHOC 2024 FEATURING Anıl Tombak
23 views
August 15, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

17:01
Hematology Content

Q&A: Panel Discussion of a Treatment Option for ITP

Feat. T. Gernsheimer, J. Bussel, L. Tolba

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Related Videos

Penn Medicine Abramson Cancer Center

2025 Breast Cancer Highlights from International Medical Meetings: 5…

Thu, Mar 6, 2025
Indy Hematology Review

22nd Annual Indy Hematology Review

Sat, Mar 8, 2025
SOHO Turkey 2025

12th SOHO Turkey Meeting

Sat, May 17, 2025
Total Health

2025 West Oncology Conference

Sat, Feb 8, 2025
15:39

Thalassemias: Overview of Pathophysiology and Treatment

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

K. Fertrin

1.2K views
25:03

New

ASH 2024 Summary: Highlights in AML, MDS, and ALL

2024 ASH Annual Meeting Insights Hub

T. Badar

409 views
17:38

Impact and Risks of Chronic Anemia in Thalassemia Patients

Farrukh Shah

747 views
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

3.7K views
27:49

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Insights from 2024 EHA Annual Meeting

T. Badar

747 views
04:54

Thalassemia: Overview of Pathophysiology and Risk for Malignancies

Ali Taher

308 views
25:44

Myeloid Malignancies: Hot Topics in 2024

Yale Cancer Center

N. Podoltsev

292 views
15:16

New

ASH 2024 Summary: Transplant Options and Outcomes for TP53 Myeloid D…

2024 ASH Annual Meeting Insights Hub

H. Fernandez

141 views
14:32

Summary of Recent Updates in MDS

Vanderbilt University Medical Center (VUMC)

S. Ball

450 views
22:37

AML and MDS Highlights & Key Takeaways

Insights from 2023 ASH Annual Meeting

T. Badar

2.2K views
23:04

Differentiation of CHIP, ICUS, CCUS, MDS, and VEXAS Syndrome

MyCancerHaven

R. Vij, S. Abedin

264 views
31:53

HSCT in 2024: What Every Hematologist Needs to Know

Indy Hematology Review

R. Childs

775 views
11:32

Laboratory Evaluation and Diagnosis of Thalassemia

Norafiza Mohd Yasin

134 views
13:08

Principles of Iron Management in Thalassemia

Nita Radhakrishnan

139 views
24:44

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

928 views
33:17

Managing Benign Hematology Disorders

Indy Hematology Review

C. Kessler

636 views
16:09

Case-Based Discussion: Managing Non-Transfusion-Dependent Thalassemia

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Taher

1.6K views
04:16

MDS and AML: Implementation of Guideline-Driven Germline Genetic Eva…

UChicago Medicine 12th International Clinical Cancer Genomics Conference

L. Banaszak

407 views
20:58

New

Defining Risk of Progression in CHIP/CCUS: A Pathologists' Perspecti…

16th International Congress on Myeloproliferative Neoplasms

R. Hasserjian

96 views
05:55

New

ASH 2024 Insights: Secondary Heme Malignancies in Myeloma Post-CAR-T…

2024 ASH Annual Meeting Insights Hub

J. Waldschmidt

73 views
AUTOPLAY